Photo detail


Stories this photo appears in:

DxTerity Stays Nimble: Customized Blood Test-Maker Moves Into Autoimmune Arena

Innovation Special Report

DxTerity Diagnostics Inc. holds $150 million in contracts for blood tests for radiation, a gene-based test that can triage residents in the aftermath of a nuclear attack.

Tease photo